MLLT3 and leukemia: We then stained MLL-AF9 primary leukemia bone marrow with antibodies against Flt3, lineage markers (Lin), Sca1, Kit, CD24, CD34, and CD16/CD32, and analyzed the samples by FACS (Figure 1A).